A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Over the last year, the stock has surged more than 450%. Drugmaker Novo Nordisk said that the Food and Drug Administration determined that the shortage of Wegovy and Ozempic, the company's blockbuster ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Novo Nordisk (NVO) announced that the U.S. Food and Drug Administration has determined the shortage of Wegovy and Ozempic is resolved. “The ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

The resolution comes two months after the health regulator said there was no longer a shortage of Eli Lilly's weight-loss and ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...